Prøve GULL - Gratis
What Is Overwhelming You?
PRIME Magazine
|April - May 2017
-
The basic symptoms of the conditions differ. Yet, each could be contributing factors to one another.
All adults would have experienced apprehension at some point in life. The cause could have been due to critical events in our life such as a job interview or a medical diagnosis. Despite all attempts of positive thinking, the fear of a negative outcome does create some physical and psychological aggravations within us. Anxiety creates great levels of uneasiness and the need to escape, which may lead to rapid heartbeats, sweating and shivers.
However, when such a condition or its symptoms are prolonged or frequent, it could indicate a call for professional intervention to treat anxiety disorders.
There comes a time in life where nothing seems to go right. The future seems bleak and thoughts focus only on the worst that could happen. All this negativity could overcome inner strength and lead to a decision to end it all. Depression slows down cognitive functions such as the ability to process information and express emotions. A lack of energy could also be caused by severe changes in appetite.
If such conditions are interfering with daily functioning, it could be indicative of depression and requires urgent psychiatric attention.
As we have seen above, the factors that cause anxiety can lead to negative thoughts and hence depression. Nipping anxiety or depression in the bud could sometimes save you or a loved one from the catastrophic impacts of these emotionally overwhelming conditions.
Denne historien er fra April - May 2017-utgaven av PRIME Magazine.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA PRIME Magazine
PRIME Singapore
Living Large
The Illusion of Space in Small Homes
9 mins
February - March 2026
PRIME Singapore
Fend Off the Flames
Fire Safety Knowledge That Can Save Lives
7 mins
February - March 2026
PRIME Singapore
The World in Numbers
How Data Analytics Shapes Modern Decision-Making
14 mins
February - March 2026
PRIME Singapore
Thunder Struck
Chris Hemsworth: From God of Thunder to Hollywood Deity
29 mins
February - March 2026
PRIME Singapore
Ingesting Inflammation
Why Everyone is Talking About Anti-Inflammatory Diets
12 mins
February - March 2026
PRIME Singapore
Inked Later
Why More People Are Getting Tattoos After 40
7 mins
February - March 2026
PRIME Singapore
STUDY CONFIRMS ONE MONTH OF NO ALCOHOL MAKES REAL DIFFERENCE TO HEALTH
In 2013, Alcohol Change UK started the “Dry January” campaign, where people could commit to abstaining from drinking alcohol for the entire month.
2 mins
February - March 2026
PRIME Singapore
CERTAIN CHANGES IN DRIVING PATTERNS MAY POINT TO COGNITIVE DECLINE, DEMENTIA
Individuals with cognitive impairment are at a two-to five-fold increased risk of being involved in motor accidents, highlighting the deterioration of driving skills with a decline in cognitive function. A recent study published in Neurology suggests that changes in daily driving patterns recorded using a vehicle datalogger could reliably distinguish individuals with mild cognitive impairment (MCI) from those with normal cognition. The study’s findings suggest that data collected by vehicle data loggers could potentially be used in the early identification of individuals at risk of a motor crash or those with cognitive impairment, prior to in-person cognitive assessments or brain imaging scans. Driving data patterns could also serve as a tool to assess the effectiveness of interventions for treating cognitive impairment.
2 mins
February - March 2026
PRIME Singapore
LIFT ME UP
Volformer: The Rejuvenation Protocol Combining Precision Ultrasound and Volumetric RF
4 mins
February - March 2026
PRIME Singapore
TARGETING IDO1 FOR CANCER: NOVEL DEGRADERS SHOW PROMISE IN PRECLINICAL STUDIES
Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these escape mechanisms. However, such therapies are not always successful. A research team from the Max Planck Institute for Molecular Physiology in Dortmund and the AITHYRA Institute in Vienna has now developed a new class of compounds that specifically target and destroy the enzyme IDO1 – a key molecular switch that tumours use to suppress immune responses. They were also able to show that iDegs (IDO1 degraders) inhibit tumour growth in mice with SKOV-3 tumours, thereby prolonging survival time. This approach could markedly enhance the efficacy of existing immunotherapies and open new avenues in the fight against cancer. The new research was published in the journal Nature.
3 mins
February - March 2026
Translate
Change font size

